Osstem Implant Buys Brazil’s 3rd Largest Dental Implant Company

SOUTH KOREA: Dental implant solutions provider Osstem Implant has announced its acquisition of Implacil de Bortoli, a prominent Brazilian dental company, for a sum nearing $89.8 million.

With the finalization of the deal on April 13, Osstem now holds complete ownership of Implacil de Bortoli, a company that commands more than 14 percent of Brazil’s dental implant market share. Established in 1982, Implacil de Bortoli is ranked third in Brazil’s dental market and offers an extensive array of dental solutions, encompassing over 1,300 products ranging from implants to prosthetics and biomaterials.

Osstem Implant Promotes Global Hub for Dental Training

Robust Growth and Strategic Fit

Implacil de Bortoli has exhibited robust growth, with a remarkable annual revenue increase averaging 50.8 percent from 2020 to 2023, coupled with an impressive EBITDA growth rate of 60.4 percent. Osstem’s acquisition aligns with its “Bolt-on” strategy, aimed at fortifying market dominance and leveraging synergies through strategic acquisitions within the dental industry.

Osstem anticipates significant cross-selling opportunities between its existing product lines and those of Implacil de Bortoli, not only in Brazil but also across South America. The company envisions leveraging its advanced R&D technologies to augment Implacil de Bortoli’s product offerings, further solidifying its foothold in the local market.

Financing and Closure Timeline

Funding for the acquisition is reported to be drawn from Osstem’s U.S. subsidiary, Hiossen Inc.’s surplus cash. The deal is slated for closure by the end of May, signaling Osstem’s commitment to swift integration and capitalizing on the strategic advantages offered by this acquisition.

Osstem Implant Explores Dental Equipment Plant in Saudi Arabia